0001127602-12-020208.txt : 20120618
0001127602-12-020208.hdr.sgml : 20120618
20120618135343
ACCESSION NUMBER: 0001127602-12-020208
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120615
FILED AS OF DATE: 20120618
DATE AS OF CHANGE: 20120618
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ALEXANDER SUSAN H
CENTRAL INDEX KEY: 0001263839
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19311
FILM NUMBER: 12911994
MAIL ADDRESS:
STREET 1: C/O BIOGEN IDEC INC.
STREET 2: 14 CAMBRIDGE CENTER
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOGEN IDEC INC.
CENTRAL INDEX KEY: 0000875045
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 330112644
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 133 BOSTON POST ROAD
CITY: WESTON
STATE: MA
ZIP: 02493
BUSINESS PHONE: 7814642000
MAIL ADDRESS:
STREET 1: 133 BOSTON POST ROAD
CITY: WESTON
STATE: MA
ZIP: 02493
FORMER COMPANY:
FORMER CONFORMED NAME: BIOGEN IDEC INC
DATE OF NAME CHANGE: 20031112
FORMER COMPANY:
FORMER CONFORMED NAME: IDEC PHARMACEUTICALS CORP / DE
DATE OF NAME CHANGE: 19970530
4
1
form4.xml
PRIMARY DOCUMENT
X0305
4
2012-06-15
0000875045
BIOGEN IDEC INC.
BIIB
0001263839
ALEXANDER SUSAN H
BIOGEN IDEC INC.
133 BOSTON POST ROAD
WESTON
MA
02493
1
EVP, General Counsel
Common Stock
2012-06-15
4
M
0
20000
45.72
A
30185
D
Common Stock
2012-06-15
4
M
0
29800
49.31
A
59985
D
Common Stock
2012-06-15
4
S
0
49800
140.00
D
10185
D
Stock Option (Right to Buy)
45.72
2012-06-15
4
M
0
20000
0
D
2016-02-15
Common Stock
20000
0
D
Stock Option (Right to Buy)
49.31
2012-06-15
4
M
0
29800
0
D
2017-02-12
Common Stock
29800
0
D
Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
Granted under one of the Issuer's stock option plans, in an exempt transaction under SEC rule 16(b)-3(d).
The stock option becomes exercisable in four (4) equal annual installments, commencing one year after the grant date of 02/15/06.
The stock option becomes exercisable in four (4) equal annual installments, commencing one year after the grant date of 02/12/07.
Aras Lapinskas, Attorney in Fact for Susan H. Alexander
2012-06-18